TWST (Twist Bioscience) Institutional Ownership: 118.75% (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TWST Twist Bioscience Corp TWST
69 GF Score
Price $113.19
GF Value $52.17
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Twist Bioscience Institutional Ownership?

Twist Bioscience TWST +3.76% 69 Institutional Ownership is 118.75% as of Aug. 07, 2026. GuruFocus rates TWST with a GF Score™ of 69/100 and a GF Value™ of $52.17 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Twist Bioscience's institutional ownership is 118.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Twist Bioscience's Insider Ownership is 4.77%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Twist Bioscience's Float Percentage Of Total Shares Outstanding is 78.10%.

Twist Bioscience Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Twist Bioscience's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Twist Bioscience Institutional Ownership Chart

Twist Bioscience Historical Data

The historical data trend for Twist Bioscience can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 91.30 95.12 95.52 94.93 97.02 94.97 97.10 94.30 96.13 97.52
TWST
69GF Score
Twist Bioscience Corp TWST
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Twist Bioscience Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 118.75% mean?
Twist Bioscience (TWST) has a Institutional Ownership of 118.75% as of Aug. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Twist Bioscience and its competitors.
Is Twist Bioscience's Institutional Ownership too high?
Twist Bioscience's current Institutional Ownership is 118.75%. Overall, Twist Bioscience has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Twist Bioscience's Institutional Ownership compare to BLLN and SHC?
Twist Bioscience's Institutional Ownership of 118.75% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Twist Bioscience and its competitors. Twist Bioscience's current Institutional Ownership is 118.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Twist Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Twist Bioscience (TWST) is currently considered Significantly Overvalued. The stock's GF Value™ is $52.17, compared to a current price of $113.19 — trading 117% above its estimated fair value. The current Institutional Ownership is 118.75%. Twist Bioscience's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Twist Bioscience (TWST), the current Institutional Ownership is 118.75% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Twist Bioscience (TWST) Overvalued in 2026?

Based on GuruFocus' analysis, Twist Bioscience stock appears to be overvalued. The current stock price of $113.19 is trading 117% above its estimated GF Value™ of $52.17. GuruFocus considers Twist Bioscience to be Significantly Overvalued.

Key valuation signals for TWST:

  • Institutional Ownership: 118.75%
  • GF Value™: $52.17 vs. price of $113.19 (117% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the TWST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Twist Bioscience Business Description

Other Exchanges 1TWST:Italy0ME:Germany
Address 681 Gateway Boulevard, South San Francisco, CA, USA, 94080
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
69GF Score

Get the complete analysis for TWST

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$113.19
Price
$52.17
GF Value